In my previous article, I made three important arguments about leaders’ efforts and responsibility to enhance the justice, equity, diversity and inclusion (JEDI) of their work and impact in their ...
For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...
Bala V Sathyanarayanan serves as EVP & CHRO at Greif, Inc (NYSE: GEF) & Chairman of the Board of Directors at Balmer Lawrie - Van Leer Ltd. Organizations face unprecedented opportunities and ...
The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results